Vanda Pharmaceuticals | VNDA - Stock

Aktienkurs
7.06
Täglich Wechseln
-0.06 -0.84%
Monatlich
-13.59%
Jährlich
46.47%
Q1 Prognose
6.91




Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.59B 126M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.07M 11.1M 2025-12
J&J USD 14.19B 45M 2025-12
Lexicon Pharmaceuticals USD 168K 33K 2025-06
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Veracyte USD 20.55M 219K 2025-12